Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections.
about
Surgical controversies in the management of post-chemotherapy nonretroperitoneal residual disease in metastatic nonseminomatous germ cell tumorsPostchemotherapy surgery for germ cell tumors--what have we learned in 35 years?Canadian consensus guidelines for the management of testicular germ cell cancer.Current status and future perspectives in the treatment of advanced testicular cancer.Management of the residual post-chemotherapy retroperitoneal mass in germ cell tumors.Laparoscopic retroperitoneal lymph node dissection for testicular cancer.A meta-analysis of patient outcomes with subcentimeter disease after chemotherapy for metastatic non-seminomatous germ cell tumor.Development of a risk stratification system to guide treatment for female germ cell tumors.A review of second-line chemotherapy and prognostic models for disseminated germ cell tumors.Treatment of relapsed/refractory germ cell tumours: an equipoise between conventional and high dose therapy.Management of residual mass in nonseminomatous germ cell tumors following chemotherapy.Outcomes following retroperitoneal lymph node dissection in postchemotherapy residual masses in advanced testicular germ cell tumors.Postchemotherapy changes in testicular germ cell tumours: biology and morphology.Pelvic Lymph Node Dissection in Patients Treated for Testis Cancer: The Memorial Sloan Kettering Cancer Center ExperienceRecent developments in the management of germ cell tumors.Clinical Outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors.Resection of residual retroperitoneal masses in testicular cancer: evaluation and improvement of selection criteria. The ReHiT study group. Re-analysis of histology in testicular cancer.Surgery for retroperitoneal relapse in the setting of a prior retroperitoneal lymph node dissection for germ cell tumor.Management of poor-prognosis testicular germ cell tumors.Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis.Sequential resection of residual abdominal and thoracic masses after chemotherapy for metastatic non-seminomatous germ cell tumours.Prognosis after salvage treatment for unselected male patients with germ cell tumours.DNA topoisomerase I and II expression in drug resistant germ cell tumoursPrediction of relapse after lymph node dissection for germ cell tumours: can salvage chemotherapy be avoided?Benign neck metastasis of a testicular germ cell tumor.Post-chemotherapy nerve-sparing laparoscopic retroperitoneal lymph node dissection in stage IIB testicular cancer.Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection.Post chemotherapy retroperitoneal lymph node dissection in germ cell tumor: robotic way.
P2860
Q26750585-D4B16E72-A12F-401D-AC6E-A3D580A0B26FQ33577850-58A950D9-7624-43FE-A218-B664D9DB1DC2Q33753786-DDB32960-49CF-4B57-AD9E-D596BEA8543DQ34612225-3E6042CF-6423-4220-BDA7-7409C98DA7A5Q35076383-BBDD5C85-87EA-407E-91C8-1C639DB7EF50Q35642983-4291E02A-9D0D-4D2D-B77A-D81AAB2B589BQ36049048-FD37AC14-93A7-4C57-9058-BDD34D827884Q37234753-CC6A4CA6-74AA-4D23-B9D8-B4504296A459Q37875412-388272AE-BF52-41AC-B63B-4DEC1D39BCC5Q38012658-893D377B-FE71-4CAE-B301-9262ABF0B392Q38509309-1AE935EC-34B5-4DC7-93B7-32352ECBA79DQ38527169-E19A207F-F3C9-4AC8-9266-690DB1B2BBACQ38783396-D41B51E7-7E66-42C3-9CC9-7635A429F7C0Q38846914-CE3F6531-C35A-400F-8B46-868825D6BC8DQ38984439-78A4C4A7-B114-4174-8535-37DAFA9D95DAQ39308370-24C23C5E-99CB-4430-B487-150771300D8DQ40000083-2D29ABB7-0CA1-4E89-B37B-73E0941D13F5Q40810822-672F8BDB-75E5-4500-B4BF-0BE1975444B3Q40810851-9605FF34-7818-40D2-8815-44D31DDA0CC5Q40811528-027E206E-EC6B-44F7-ABFC-C56E8F784DBBQ41925985-0B927373-FDFA-4274-BA3E-B3BB68322D80Q42005271-91F794AA-276F-42AE-B69B-FFE11EE5D63FQ42005856-64F146A5-BF1A-41FA-BD03-260613301934Q42126258-E686F51F-867C-4E38-9E64-5060E7E2EF3FQ43113751-131726B7-A923-4797-8CAA-FB54459DC367Q46006837-83F196EA-6260-4832-BE78-FA8D813CA8CEQ46509605-0F9ECCE6-7D17-4169-86EB-A1F1FCEC1B9DQ52977990-74557200-1B8B-4FF2-84A4-3B478ACAF4D8
P2860
Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Outcome analysis for patients ...... toneal lymph node dissections.
@en
type
label
Outcome analysis for patients ...... toneal lymph node dissections.
@en
prefLabel
Outcome analysis for patients ...... toneal lymph node dissections.
@en
P2093
P1476
Outcome analysis for patients ...... toneal lymph node dissections.
@en
P2093
J P Donohue
L H Einhorn
P J Loehrer
S D Williams
T D Weathers
T M Ulbright
P304
P356
10.1200/JCO.1993.11.7.1294
P407
P577
1993-07-01T00:00:00Z